Table: Daito -Q1 group results

Daito Pharmaceutical

12/10/2023 07:00

Oct 12 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Aug 31, 2023        Aug 31, 2022     May 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             12.18               12.04            47.50    
                 (+1.1 pct)          (+2.5 pct)       (+5.3 pct)  
  Operating          1.08                1.50             4.80    
                 (-28.0 pct)         (-36.4 pct)      (-7.8 pct)  
  Recurring          1.09                1.48             4.80    
                 (-26.0 pct)         (-39.0 pct)      (-7.1 pct)  
  Net              683 mln             946 mln            3.30    
                 (-27.7 pct)         (-48.2 pct)      (-8.3 pct)  
  EPS             43.27 yen           59.74 yen       208.82 yen  
  Ann Div                             60.00 yen        60.00 yen  
  -Q2 div                             30.00 yen        30.00 yen  
  -Q4 div                             30.00 yen        30.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T